Told India no safety concern with its Covid-19 vaccine: Pfizer
3 years, 10 months ago

Told India no safety concern with its Covid-19 vaccine: Pfizer

India Today  

Pfizer Inc said on Monday it told the Indian government that there was no concern over the safety of its COVID-19 vaccine, as the country insists on small local trials for foreign shots despite a record surge in infections and shortage of doses. The government in mid-April made it easier for foreign vaccines approved in the West and Japan to sell in India, though companies would still have to initiate a local clinical trial within 30 days of receiving emergency use authorization. "Pfizer's application for emergency use authorization was supported with data that shows an overall efficacy rate of 95% with no safety concerns," a company spokeswoman told Reuters, when asked if it had sought an exception even to the current trial rule in its discussions with the government. Asked about the vaccine's ultra-low temperature storage requirements - minus 70 degrees Celsius - Pfizer said the company could deliver the shot to vaccination centers using its specially designed, temperature-controlled thermal shippers.

India Vaccine Pfizer  pfizer  vaccines  vaccine  covid19  sell  concern  local  safety  trial  days  india  told  supply

History of this topic

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official
10 months, 1 week ago

AstraZeneca's Covishield Showed Lowest Incidence of Side Effects in India Versus Globally, Says Top Govt Official

News 18  

AstraZeneca’s vaccine has demonstrated the lowest incidence of side effects in India compared to the global average, a top government official involved in the national roll-out of Covid-19 vaccination told News18. “But only around 50 cases witnessed Thrombosis with Thrombocytopenia Syndrome — a rare side effect caused by the jab — of the 180 crore doses administered against 4 to …

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021
10 months, 1 week ago

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021

Live Mint  

New Delhi: The Serum Institute of India on Wednesday said it has stopped making and supplying covid-19 vaccine Covishield after AstraZeneca, the British drugmaker that helped develop the vaccine, announced it too was withdrawing its version of the jab worldwide. The development follows the launch of a class action suit in the UK over allegations that the UK vaccine caused …

AstraZeneca pulls its COVID-19 vaccine from the European market
10 months, 1 week ago

AstraZeneca pulls its COVID-19 vaccine from the European market

Associated Press  

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca’s COVID-19 vaccine was first given …

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns
10 months, 2 weeks ago

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns

India TV News  

In response to recent concerns regarding potential rare side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical company has underscored its unwavering commitment to patient safety while affirming the vaccine's overall safety profile. This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, …

Health chiefs 'failed to sound alarm over potential dangers of Covid vaccines': MPs accuse regulator of putting Brits 'at serious risk' by not immediately sharing how Pfizer jabs could trigger extreme
1 year ago

Health chiefs 'failed to sound alarm over potential dangers of Covid vaccines': MPs accuse regulator of putting Brits 'at serious risk' by not immediately sharing how Pfizer jabs could trigger extreme

Daily Mail  

Britain's medicines regulator has been accused of failing to sound the alarm over Covid jab side effects, despite allegedly knowing of heart risks for months before warnings were issued. The AAPG letter, penned by its co-chair Graham Stringer the Labour MP for Blackley and Broughton, called for an urgent investigation to be held into The Medicines and Healthcare products Regulatory …

With State prod, India can be world leader in vaccines
1 year, 1 month ago

With State prod, India can be world leader in vaccines

Hindustan Times  

The World Health Organization activated its incident management support team as part of its emergency response framework on the emergence of a cluster of atypical pneumonia cases emerging from Wuhan, China, on January 1, 2020. India, the dark horse in the vaccine race, did the unexpected and against all odds, approving EUA to two vaccines — “made in India” Covishield …

US FDA authorizes Pfizer-BioNTech, Moderna's updated Covid shots
1 year, 6 months ago

US FDA authorizes Pfizer-BioNTech, Moderna's updated Covid shots

India Today  

The U.S. Food and Drug Administration on Monday authorized updated Covid-19 vaccines from Pfizer/BioNTech and Moderna that target a recently circulating Omicron variant of the coronavirus, paving the way for the launch later this week of a fall vaccination campaign. Pfizer and Moderna said their updated vaccines, which target the XBB.1.5 subvariant of the virus, were expected to be available …

A new regime: On the Emergency Use Authorisation regime in India and clinical trials
1 year, 8 months ago

A new regime: On the Emergency Use Authorisation regime in India and clinical trials

The Hindu  

Last week, the Drug Controller General of India cleared, under the provisions of ‘emergency use authorisation’, a new mRNA vaccine for COVID-19 developed by Pune-based Gennova Biopharmaceuticals, a pioneer in India in developing mRNA vaccines. More than evidence-based assessment, it was a technicality in India’s ‘New Drugs and Clinical Trials Rules, 2019’ that allowed EUA in India for COVID-19 vaccines. …

India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose
1 year, 8 months ago

India-made mRNA vaccine priced at ₹2,292, will be available as a booster dose

The Hindu  

India’s first indigenously developed mRNA vaccine against the dominant Omicron variant of the COVID-19 coronavirus will cost ₹2,292, Sanjay Singh, CEO, Gennova Biopharmaceuticals, said at a press conference on June 24. The vaccine will for now only be available as a booster or “precaution dose”, that is, somebody who has already been vaccinated thrice will be ineligible as the relevant …

India urges G-20 countries to join vaccine research collaborative in wake of COVID vaccine inequity
1 year, 9 months ago

India urges G-20 countries to join vaccine research collaborative in wake of COVID vaccine inequity

The Hindu  

With the COVID-19 pandemic exposing the acute inequity in vaccine development and access, the Indian government is working in partnership with two leading global non-profits to convene and build consensus among the G-20 member States and others, for a proposed Global Vaccine Research Collaborative. “International cooperation is essential to advance vaccine development for emerging pathogens, and the G-20 can serve …

India’s Winning Formula: Making Healthcare Affordable and Accessible with PPPs
1 year, 9 months ago

India’s Winning Formula: Making Healthcare Affordable and Accessible with PPPs

News 18  

In the last 75 years, India’s progress as a nation has been both inspiring and impressive. Vaccine PPPs during the Covid-19 pandemic It is during the pandemic that India gained a definite advantage in the global health space, when it administered the first dose of the indigenous Covid-19 vaccine Covaxin, in January 2021. Within a year of the emergence of …

India restarts Covid vaccine production as new infections soar 30% in one day
1 year, 11 months ago

India restarts Covid vaccine production as new infections soar 30% in one day

The Independent  

India is ramping up its vaccine production following a rapid surge in Covid-19 cases driven by a new subvariant dubbed Arcturus. The country recorded 10,158 news Covid cases on Thursday, a 30 per cent surge in one day, according to the federal health ministry data. The company stopped manufacturing Covishield in December 2021 due to dwindling demand and a low …

Serum Institute could resume Covishield production as Covid cases rise
1 year, 11 months ago

Serum Institute could resume Covishield production as Covid cases rise

Live Mint  

The Serum Institute of India could resume production of the Covishield Covid-19 vaccine as infections rise in the country, a company spokesperson said on Wednesday. Dr Amitav Banerjee - an epidemiologist who leads DY Patil Medical College in Pune has earlier said that Covishield carried a ‘double whammy of risk’. Many would perhaps not know that Covishield carries a DNA …

India sees over 7,800 COVID cases in a day reported on April 12, 2023
1 year, 11 months ago

India sees over 7,800 COVID cases in a day reported on April 12, 2023

The Hindu  

Omicron XBB and its variants are responsible for the current surge in COVID-19 cases, but this is not a cause for worry as the severity of this variant is currently below average, with less hospitalisation, a senior Health Ministry official said on April 12. The Health Ministry source said that the current surge is not a “wave” but rather an …

Bihar will buy Covid vaccines in absence of supply from Centre: CM Nitish
1 year, 11 months ago

Bihar will buy Covid vaccines in absence of supply from Centre: CM Nitish

Hindustan Times  

PATNA: Chief minister Nitish Kumar said the state government would buy vaccines against coronavirus on its own to continue inoculating its people as Centre is not providing them to the state, as per a communique from the chief minister’s office on Monday. The communique, however, was silent on the state’s unmet demand for Covid-19 vaccines, how it would buy them …

'Force to Reckon With in Near Future': Ex-ICMR DG Praises Govt’s 'Deliberate' Call to Give Free Covid Jabs
1 year, 11 months ago

'Force to Reckon With in Near Future': Ex-ICMR DG Praises Govt’s 'Deliberate' Call to Give Free Covid Jabs

News 18  

It was the Narendra Modi government’s deliberate and concerted decision to deliver free Covid-19 vaccines to everyone in India unlike other countries where vaccines were sold at exorbitant prices, Dr Balram Bhargava, former director general of Indian Council of Medical Research, has said. “The issue of the pricing of vaccines in India was a deliberate effort of the government to …

‘The Vial’ trailer out: Manoj Bajpayee narrates History TV18's documentary on India’s Covid-19 vaccine journey
1 year, 11 months ago

‘The Vial’ trailer out: Manoj Bajpayee narrates History TV18's documentary on India’s Covid-19 vaccine journey

Firstpost  

India’s Covid-19 vaccination programme has proven to be the world’s largest but how did the nation, led by Prime Minister Narendra Modi, embark on this journey? To find out the details of a historic and unprecedented battle, check out History TV18’s documentary titled ‘The Vial – India’s Vaccine Story’ on March 24, 2023, at 8PM. ‘The Vial’ brings to life …

India saved 3.4mn people through Covid-19 vaccination drive: Report
2 years ago

India saved 3.4mn people through Covid-19 vaccination drive: Report

Hindustan Times  

India saved at least 3.4 million lives by undertaking a nationwide Covid-19 vaccination campaign at an unprecedented scale, said a new report released by the Union health minister, Mansukh Mandaviya, on Friday, adding that the vaccination campaign also yielded a positive economic impact by preventing a loss of $18.3 billion. India started its Covid vaccination drive on January 16, 2021, …

Efforts were on till yesterday' to defame Indian scientists who worked on Covid-19 vaccines: PM Modi in Rajya Sabha
2 years, 1 month ago

Efforts were on till yesterday' to defame Indian scientists who worked on Covid-19 vaccines: PM Modi in Rajya Sabha

Op India  

During the Motion of Thanks to the President’s Address in the Rajya Sabha on Thursday, Prime Minister Narendra Modi blamed the Opposition for working against science and technology, and India’s progress in the sector. PM Modi lambasted vested interests that tried to sell foreign vaccinations for Covid-19 in India, adding that India shocked the world by successfully developing its own …

No Matter How Hard Pfizer Tried, Centre Didn't Allow Them Here: Telangana CM KCR Alleges
2 years, 1 month ago

No Matter How Hard Pfizer Tried, Centre Didn't Allow Them Here: Telangana CM KCR Alleges

ABP News  

Chennai: Telangana Chief Minister K Chandrasekhar Rao alleged that the Centre did not allow Pfizer, a vaccine manufacturer, to enter India. According to ANI, Telangana CM and BRS chief K Chandrasekhar Rao on Tuesday said, “#WATCH | There is a company namely Pfizer, which manufactures vaccines, it was stopped from entering India during COVID-19. What was the reason?” “While the …

Why were Pfizer Covid vaccines stopped entering India, KCR asks Centre; filmmaker's dig at BRS chief- WATCH
2 years, 1 month ago

Why were Pfizer Covid vaccines stopped entering India, KCR asks Centre; filmmaker's dig at BRS chief- WATCH

India TV News  

BRS chief and Telangana Chief Minister K Chandrasekhar Rao's video on Wednesday surfaced in which he is seen questioning Centre over not allowing Pfizer's Covid vaccine in India. "There is a company namely Pfizer, which manufactures vaccines, was stopped from entering India during Covid-19. We also tried, many chief ministers also had talks with PMO and Niti Aayog but they …

Column: Moderna and Pfizer are jacking up the price of COVID vaccines. The government should stop them
2 years, 1 month ago

Column: Moderna and Pfizer are jacking up the price of COVID vaccines. The government should stop them

LA Times  

Doses of the Moderna COVID-19 vaccine wait to be administered at a clinic. That included a research grant of almost $1 billion from the government’s Biomedical Advanced Research and Development Authority, or BARDA, through 2020, plus a $1.5-billion federal purchase guarantee in 2020 for COVID vaccines before testing was even completed — a deal that materially reduced Moderna’s financial risks …

First Indian intranasal Covid vaccine by Bharat Biotech to be launched on Jan 26
2 years, 1 month ago

First Indian intranasal Covid vaccine by Bharat Biotech to be launched on Jan 26

India TV News  

Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC, the first of its kind in India, on January 26, the company's chairman and managing director Krishna Ella said here on Saturday. In December, Bharat Biotech had announced that it would sell the intranasal vaccine for Rs 325 per shot for procurement by the government and Rs 800 …

Pfizer CEO Cornered at Davos, India Saw Through Pharma Giant’s Promises Early to Not Bank on it
2 years, 1 month ago

Pfizer CEO Cornered at Davos, India Saw Through Pharma Giant’s Promises Early to Not Bank on it

News 18  

Pfizer CEO Albert Bourla being quizzed at Davos by journalists about the company’s Covid-19 vaccine has triggered the BJP to take on top Congress and AAP leaders for earlier pushing for the Pfizer shot to be brought to India. But facts show that not only was the vaccine offered by Pfizer and Moderna exorbitantly priced at over $20 for each …

Staying prepared: On scaling up the pace of COVID-19 genome sequencing
2 years, 2 months ago

Staying prepared: On scaling up the pace of COVID-19 genome sequencing

The Hindu  

Three years after strict enforcement of its Zero-COVID strategy, China abandoned it abruptly, leading to a jump in cases each day — an estimated 250 million people were infected in 20 days in December, according to the media, overwhelming hospitals and crematoria. Though this variant was found in many countries, including India, months ago, there is fear that the uncontrolled …

Your Best Shot at Fighting Covid: 28% Have Already Taken Booster Dose, Finds Survey
2 years, 2 months ago

Your Best Shot at Fighting Covid: 28% Have Already Taken Booster Dose, Finds Survey

News 18  

Amid government’s reminders for vaccine boosters in the wake of the Covid uptick in China, 28% of those surveyed by Localcircles said that they “have already taken the booster dose". However, 53% said that they “have not taken the booster dose and do not have any plans of taking it either". After the Centre’s meeting on Wednesday, Niti Aayog’s VK …

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN
2 years, 2 months ago

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN

Firstpost  

The needle-free vaccine will be available at private centres. It will be introduced on the Co-WIN platform on Friday evening New Delhi: Bharat Biotech’s intranasal COVID-19 vaccine has been approved by the Ministry of Health and Family Welfare for inclusion in the vaccination programme as a booster dose for those above 18 years of age, official sources said on Thursday. …

Indian Army issues advisory on Covid, asks defence personnel to take safety measures
2 years, 2 months ago

Indian Army issues advisory on Covid, asks defence personnel to take safety measures

India TV News  

The Indian Army issued an advisory on Friday asking defence personnel to take up adequate measures to tackle COVID. The advisory asked them to take up measures such as the usage of face masks in closed or crowded places, practising hand sanitisation, and maintaining social distancing among others. Union Health Minister Dr Mansukh Mandaviya is set to hold a virtual …

SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose
2 years, 2 months ago

SII Seeks Drug Regulator's Nod for Market Authorisation of Covovax Vaccine as Covid-19 Booster Dose

News 18  

The Serum Institute of India has sought the drug regulator’s approval for market authorisation of its COVID-19 vaccine Covovax as a booster dose for those aged 18 years and above who have been administered two doses of Covishield or Covaxin, official sources said on Thursday. Prakash Kumar Singh, director, government and regulatory affairs, SII, submitted a market authorisation application for …

Three reasons India will not see a Covid-wave like China’s
2 years, 2 months ago

Three reasons India will not see a Covid-wave like China’s

Hindustan Times  

The Union health ministry reviewed the Covid-19 situation in India on Wednesday in light of a surge in cases in China and other countries such as Japan, South Korea, Brazil and the United States. Since China is the only big country where cases are at an all-time high, it is important to consider if India is protected against the factors …

Covid-19: Serum Institute seeks drug regulator's approval for market authorisation of Covovax as booster dose
2 years, 2 months ago

Covid-19: Serum Institute seeks drug regulator's approval for market authorisation of Covovax as booster dose

India TV News  

Covid-19: Serum Institute seeks drug regulator's approval for market authorisation of Covovax as booster dose Covid-19: Earlier on October 17, Prakash Kumar Singh, director of government and regulatory affairs at SII, submitted a market authorization application to the Drug Controller General of India for the heterologous booster dose of Covovax. Covid-19: As the threat of coronavirus is far from over, …

Covid-19: Govt mulls mandating forms with RT-PCR, vaccination details for air travellers from abroad
2 years, 2 months ago

Covid-19: Govt mulls mandating forms with RT-PCR, vaccination details for air travellers from abroad

India TV News  

Covid-19: Govt mulls mandating forms with RT-PCR, vaccination details for air travellers from abroad Covid-19: According to reports, the ministry will take a decision on it after examining the situation for the next few weeks. Covid-19: Amid the growing threat of the latest Omicron variant, the Union health ministry is mulling to reintroduce the mandatory 'air suvidha' forms with details …

A PLI-type scheme for 'atmanirbhar' vaccine industry
2 years, 2 months ago

A PLI-type scheme for 'atmanirbhar' vaccine industry

Live Mint  

The government will likely unveil a ₹2,500 crore financial assistance programme to boost domestic production of vaccine raw materials to enhance self-reliance amid a resurgence of covid cases worldwide, two officials familiar with the development said. Cement investors see Q3 with mixed feelings While India is a global leader in vaccine production, it imports key raw materials needed for manufacturing. …

BioNTech-Pfizer COVID vaccine sent to China for Germans
2 years, 2 months ago

BioNTech-Pfizer COVID vaccine sent to China for Germans

Associated Press  

BERLIN — Germany has dispatched a batch of the BioNTech-Pfizer COVID-19 vaccine to China, where it will be administered to Germans who live in the country. He said that the Chinese government formally informed Berlin in a diplomatic note that German citizens can be inoculated with the vaccine, which otherwise isn’t cleared for use in China. Some 20,000 Germans in …

India need not panic given excellent COVID-19 vaccination coverage: Adar Poonawalla
2 years, 2 months ago

India need not panic given excellent COVID-19 vaccination coverage: Adar Poonawalla

The Hindu  

Serum Institute of India CEO Adar Poonawalla on Tuesday expressed concern over reports of a rising COVID-19 graph in China but said there is no need to panic as the vaccination coverage in India is excellent. Mr. Poonawalla's tweet came a day after the Union Health Ministry urged all states and UTs to ramp up the whole genome sequencing of …

'Rising Covid cases in China concerning,' says Serum Institute's Adar Poonawalla
2 years, 2 months ago

'Rising Covid cases in China concerning,' says Serum Institute's Adar Poonawalla

Hindustan Times  

Raising concern on the rising COVID-19 cases in neighbouring China, Serum Institute of India CEO Adar Poonawala on Wednesday asked the people not to panic because of India's "excellent vaccination coverage and track record". Expressing concern over the spurt in Covid-19 cases in China, former Indian diplomat KP Fabian on Tuesday said, "over 60 per cent of China and 10 …

New Year, Old Fear: China's Covid Surge Shows Why India Can Breathe Sigh of Relief For Now
2 years, 2 months ago

New Year, Old Fear: China's Covid Surge Shows Why India Can Breathe Sigh of Relief For Now

News 18  

It was a long haul away from Zero Covid for China. “Population immunity is much higher in India and our research suggests that most people have already been infected with Omicron, with a large fraction having had both Delta and Omicron infections,” said Agrawal. Additional immunity provided by India’s large vaccination programme reduces the potential for major impact, he said, …

COVID-19 vaccine: How well does India’s adverse reaction tracking system work? | In Focus podcast
2 years, 2 months ago

COVID-19 vaccine: How well does India’s adverse reaction tracking system work? | In Focus podcast

The Hindu  

Last month, the Central government, in an affidavit to the Supreme Court, said that it cannot be held liable to pay compensation for deaths caused by adverse reactions to the COVID-19 vaccine. The affidavit was filed in a case in response to a petition filed by the parents of two young women, who allegedly died due to adverse reactions following …

report highlights irregularities in FDA approval of COVID-19 vaccines, drugs
2 years, 3 months ago

report highlights irregularities in FDA approval of COVID-19 vaccines, drugs

The Hindu  

Published : Dec 14, 2022 20:22 IST An investigation by a journalist, Maryanne Demasi, of official regulatory documents of the US Food and Drug Administration has highlighted irregularities in the agency’s approval of the vaccines and drugs for COVID-19 developed under “Operation Warp Speed”, a public-private partnership initiated by the US government. According to the report, only nine out of …

Bharat Biotech urges Centre to include its intranasal COVID vaccine in CoWIN portal
2 years, 3 months ago

Bharat Biotech urges Centre to include its intranasal COVID vaccine in CoWIN portal

Deccan Chronicle  

Hyderabad: Bharat Biotech has requested the central government to include its intranasal COVID-19 vaccine iNCOVACC, in CoWIN portal to enable the recipients of the jab to get vaccination certificate. The company sources said Bharat Biotech is currently holding discussions with international “potential partners” who have approached the company for manufacturing and distribution of the intranasal vaccine globally. “Since iNCOVACC has …

No Wastage of Covid Vaccines in Govt Buffer Stock Due to Expiry: Govt in Lok Sabha
2 years, 3 months ago

No Wastage of Covid Vaccines in Govt Buffer Stock Due to Expiry: Govt in Lok Sabha

News 18  

There has been no wastage of COVID-19 vaccines in the government buffer stock due to expiry, Union minister Bharati Pravin Pawar informed Lok Sabha on Friday. The central government closely monitors COVID-19 vaccine stocks in states and Union territories so as to ensure their optimal utilisation and minimal wastage, Pawar said in written reply to a question. To ensure utilisation …

Government Not Liable To Compensate For Deaths Due To COVID Vaccination : Centre Tells Supreme Court
2 years, 3 months ago

Government Not Liable To Compensate For Deaths Due To COVID Vaccination : Centre Tells Supreme Court

Live Law  

The Government cannot be held liable to compensate for the deaths occurring due to the administration of COVID-19 vaccines, said the Central Government in an affidavit filed before the Supreme Court.Responding to a petition filed by parents of two girls who died due to the adverse effects of Covishield vaccine, the Union Government submitted that : "The vaccines in use …

What Makes India's Covid Vaccination Programme A Global Best Practice In Public Health
2 years, 4 months ago

What Makes India's Covid Vaccination Programme A Global Best Practice In Public Health

News 18  

On April 14, 2020, India’s Prime Minister made an appeal to scientists and researchers to take the lead in developing a vaccine against the coronavirus. The group was tasked with formulating an implementation strategy for the Covid-19 vaccine including the selection of vaccine candidates, procurement of vaccines, prioritisation of population groups for vaccination, enabling digital infrastructure, vaccine delivery platforms as …

Afraid of needles? China using inhalable COVID-19 vaccine
2 years, 4 months ago

Afraid of needles? China using inhalable COVID-19 vaccine

Associated Press  

BEIJING — The Chinese city of Shanghai started administering an inhalable COVID-19 vaccine on Wednesday in what appears to be a world first. The vaccine, a mist that is sucked in through the mouth, is being offered for free as a booster dose for previously vaccinated people, according to an announcement on an official city social media account. Chinese regulators …

Donations of vaccines, medicines during Covid-19 peak made India a partner of choice for UN: Antonio Guterres
2 years, 4 months ago

Donations of vaccines, medicines during Covid-19 peak made India a partner of choice for UN: Antonio Guterres

Firstpost  

India’s voice on the global stage and international meets can only gain in authority and credibility from a strong commitment to inclusivity and respect for human rights at home, Guterres said New Delhi: India has increased its impact on the global stage by stepping up at the height of the Covid-19 pandemic and helping nations in need with donations and …

Health Ministry not to procure fresh COVID-19 vaccines; surrenders ₹4,237 crore from vaccination budget
2 years, 4 months ago

Health Ministry not to procure fresh COVID-19 vaccines; surrenders ₹4,237 crore from vaccination budget

The Hindu  

The government’s COVID-19 vaccination programme is in its final leg with the Health Ministry deciding against procuring more vaccines as of now and surrendering ₹4,237 crore, or nearly 85% of the 2022-23 budget allocation for inoculation purposes, to the Finance Ministry. Official sources told PTI that more than 1.8 crore doses are still available with the governments at the Centre …

How the COVID-19 pandemic altered the vaccine story in India
2 years, 5 months ago

How the COVID-19 pandemic altered the vaccine story in India

The Hindu  

Last week, Twitter temporarily blocked a post by Florida’s surgeon general Joseph A. Ladapo. Such DNA vaccines, older in provenance than mRNA vaccines, involve inserting DNA for an antigen — or the part of the virus that stimulates the immune system — into a special kind of circular DNA called plasmids that are usually only found in bacteria. In the …

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial
2 years, 5 months ago

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial

News 18  

In a major setback, AstraZeneca and the University of Oxford’s joint trial for the nasal-spray version of the Nonreplicating viral vector vaccine against Covid-19 did not yield desired protection, reported Reuters on Tuesday. The University of Oxford said, “An antibody response in the respiratory mucous membranes was seen in only a minority of participants in the trial, which was in …

Moderna will not bow to China’s coercion, refuses to give COVID-19 vaccine recipe over ‘safety’ concerns
2 years, 5 months ago

Moderna will not bow to China’s coercion, refuses to give COVID-19 vaccine recipe over ‘safety’ concerns

Firstpost  

China hasn’t approved any foreign vaccine and has been insisting on sharing the technology behind the Moderna vaccine as a prerequisite for allowing its sale in the country New Delhi: American pharma company Moderna has refused to accept China’s condition to share the technology behind its COIVD-19 vaccine as a prerequisite for approving it citing ‘safety’ concerns, derailing the negotiations …

The Largest Vaccination Drive: Victory of People, Process and Technology
2 years, 5 months ago

The Largest Vaccination Drive: Victory of People, Process and Technology

News 18  

On the occasion of the celebration of 75 years of India’s Independence, Azadi Ka Amrit Mahotsav, the Government of India under the leadership of PM Narendra Modi was able to inoculate over a billion people with more than 217 crore vaccination doses across different age groups, diverse communities and regions within the span of 18 months after the general availability …

Discover Related